SIONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Sionna Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$4.01+0.12 (+3.08%)
Close on Oct 19, 2026
- Market cap
- $181.05M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$27.92 (−87.44%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $181.05M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.68
- Dividend yield
- –
- Free cash flow yield
- -42.09%
Fundamentals
- Net income
- -$97.38M
- EPS, diluted
- -$2.18
- Free cash flow
- -$76.21M
- Book value per share
- $5.89
- Diluted shares
- 45M
Three years at a glance
Fiscal years 2023 to 2025 and trailing twelve months, USD
Operating income
-$109.49M
Net income
-$97.38M
EPS, diluted
-$2.18
Free cash flow
-$76.21M
Reported periodTrailing twelve months